Skip to content

To study the effect of Thyroidinum 3X as an Interventional medicine for Paediatric Hypothyroidism

A COMPARATIVE CLINICAL ANALYSIS OF THE EFFECTIVENESS OF THYROIDINUM 3X AS AN INTERVENTIONAL TREATMENT FOR PAEDIATRIC HYPOTHYROIDISM - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062939
Enrollment
30
Registered
2024-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: Thyroidinum 3X: 3 x TDS, ALONG WITH CONSTITUTIONAL MEDICINE ( SINGLE DOSE) ORALLY FOR A PERIOD OF 1MONTH UNTIL NEXT FOLLOW UP Control Intervention1: HOMOEOPATHIC CONSTITUTIONAL MEDICIN

Sponsors

Apparna Ilankumaran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients within the Paediatric age group 1-18 years of age. Patients of both sexes. Patients diagnosed with Clinical and Subclinical Hypothyroidism Patients with a TSH level below 20mUI/ml

Exclusion criteria

Exclusion criteria: Patients with congenital and autoimmune thyroid disorders Patients with other systemic diseases

Design outcomes

Primary

MeasureTime frame
Paediatric Hypothyroidism is one of the areas of increasing concern in the present-day generation. With various other research being conducted in the area of hypothyroidism, the Homoeopathic method of treatment serves to be one of the safer and gentler methods for the restoration of health. The outcomes of this study pave way for the further research to be done and also help us to identify the validity of the use of Thyroidinum 3 X in such cases.Timepoint: General follow up every month, with TDT review every 3 months

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactApparna Ilankumaran

Sarada Krishna Homoeopathic Medical college

mahaiyapp338@gmail.com9487417921

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026